Novoheart (NVH) Stock Price, News & Analysis

Company Overview

Novoheart Holdings Inc. operates as a stem cell biotechnology company in the United States. The company offers an array of next-generation human heart tissue prototypes. It provides MyHeart platform products, including human pluripotent stem cell-derived cardiomyocytes, human ventricular cardiac anisotropic sheet assays, and human ventricular cardiac tissue strips assays. The company also offers screening and phenotyping services; and consultation services, including mapping and designing preclinical studies that involve human embryonic or induced pluripotent stem cell-derived cardiomyocytes, prototyping custom bioreactor designs, and developing custom software for streamlining of screening platforms and analysis of acquired data. Novoheart Holdings Inc. has a collaboration with AstraZeneca to develop human-specific in vitro functional model of heart failure with preserved ejection fraction. The company is based in Vancouver, Canada.

Key Stats

• Today's Range: C$0.52 to C$0.53
• 50-Day Range: C$0.53 to C$0.53
• 52-Week Range: C$0.26 to C$0.72
• Volume: 23,066 shs
• Average Volume: 33,593 shs
• Market Capitalization: C$99.98 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NVH Stock Analysis - Frequently Asked Questions

How have NVH shares performed this year?

Novoheart's stock was trading at C$0.53 at the beginning of 2024. Since then, NVH shares have increased by 0.0% and is now trading at C$0.53.
View the best growth stocks for 2024 here.

How do I buy shares of Novoheart?

Shares of NVH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Novoheart own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Novoheart investors own include Athabasca Oil (ATH), Black Iron (BKI), Berry (BRY), Castor Maritime (CTRM), IT Tech Packaging (ITP), SOS (SOS) and Sarepta Therapeutics (SRPT).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: CVE:NVH
• CUSIP: N/A
• CIK: N/A
• Web: www.novoheart.com
• Phone: 604-398 3170
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 27.62
• Current Ratio: 6.13
• Quick Ratio: 6.05

Sales & Book Value

• Annual Sales: C$423,500.00
• Price / Sales: 236.08
• Cash Flow: C$0.07 per share
• Price / Cash Flow: 7.46
• Book Value: C$0.12 per share
• Price / Book: 4.34

Miscellaneous

• Outstanding Shares: 188,641,000
• Free Float: N/A
• Market Cap: C$99.98 million
• Optionable: Not Optionable
• Beta: N/A